Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), such as Ozempic or Wegovy, have revolutionized type 2 diabetes and ...
With GLP-1s readily available, some experts fear misuse is increasing and may be fueling eating disorders. Physicians describe what they are seeing and how they manage the risks.
GLP-1 medications suppress appetite. What they cannot do is tell whether that appetite was disordered to begin with. For some ...
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
Multiple studies have identified that eating disorders are more common in elite athletes than in non-athlete populations. There are a wide range of types of eating disorders that can impact the oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results